13th world congress in fetal medicine...2014/01/02 · 13th world congress in fetal medicine sunday...

13th World Congress in Fetal Medicine

Nice 2014

DIAMOND SPONSOR

Invites you to the lectures:

“ 3D US in the diagnosis of fetal defects”

Speaker: Bernard Benoit

Time: 14:30-15:00 Date: Tuesday, 1st of July

&

“2D high definition linear probe in the 1st and 2nd trimesters”

Speaker: Rabih Chaoui


Invites you to the lectures:

“ 3D US in the diagnosis of fetal defects”

Speaker: Bernard Benoit


&

“2D high definition linear probe in the 1st and 2nd trimesters”

Speaker: Rabih Chaoui



Sunday 29 June 201409:20-12:40 Twin pregnancies12:40-13:00 Best practice advice for Fetal Medicine by FIGO

14:30-15:40 Fetal and postnatal surgery

18:00-18:20 Prenatal use of array CGH18:20-18:40 In utero stem cell transplantation18:40-19:00 Cell free mRNA in pregnancy diseases19:00-20:00 Fetal imaging

20:30-24:00 Welcome party

Monday 30 June 201409:00-11:00 Fetal and postnatal surgery12:10-13:00 Preterm birth

14:30-16:00 Preterm birth

18:00-20:00 Fetal conditions / interventions and preterm birth

Tuesday 1 July 201409:00-13:00 Maternal Medicine

14:30-15:30 GE Healthcare lectures15:30-15:50 Postmortem imaging

17:00-20:10 Cell-free DNA analysis of maternal blood

21:00-01:30 Dinner party in Antibes

Wednesday 2 July 201409:00-13:00 Impaired placentation

14:30-16:00 Brain abnormalities

18:00-19:40 Brain abnormalities19:40-20:00 Genes and activity in brain development

Thursday 3 July 201408:30-11:00 Fetal echocardiography11:30-12:00 Cytomegalovirus infection12:00-12:15 Prenatal diagnosis of Noonan syndrome12:15-13:00 Labor and delivery

15:00-23:00 Trip to Cannes

th

th

st

nd

rd

The Harmony Prenatal Test is a non-invasive maternal blood test for the risk assessment of fetal trisomies, such as Trisomy 21

Harmony Prenatal Test:Clear Answers to Questions that Matter

Detection Rate for Trisomy 21 1-2

O�ers the most robust clinical validation

The Harmony false-positive rate of 0.06% gives it the highest reported positive predictive value for Trisomy 21 of any cell-free DNA test 11

Backed by clinical studies in over 23,000 women of all ages 3-11

Harmony is a leading provider of NIPT

Harmony has been used in more pregnancies worldwide than any NIPT

Implemented in more than 250,000 pregnancies worldwide

Available in more than 90 countries

Early, fast results

The Harmony Prenatal Test can be performed as early as 10 weeks, with results delivered in about 7 business days

>99%

95%

85%

81%

Full-Integrated Screen

First-Trimester Screen

Quad-Marker Screen

False-positive rate:

08:00-09:10 Registration

09:10-09:20 Welcome to the World Congress Kypros Nicolaides (UK)

Eurofoetus Meeting

09:20-12:40 Twin pregnancies Discussants: Yves Ville (France), Liesbeth Lewi (Belgium)

09:20-09:40 The contribution of twin studies to genetics Isaac Blickstein (Israel)09:40-09:50 Twins: Neonatal outcome according to BW discordance Cristina Rossi (Italy)09:50-10:00 Twins: Neonatal complications and neurophysiological scores Cathrine Vedel (Denmark) 10:00-10:15 MCtwins:Classificationofcomplications LiesbethLewi(Belgium)10:15-10:25 MRI in complicated MC twins Boaz Weisz (Israel)10:25-10:35 TRAP sequence: meta-analysis of fetal interventions Petya Chaveeva (Bulgaria)10:35-10:50 Endoscopic laser in MC twins Kurt Hecher (Germany)10:50-11:00 Evolution in stage 1 TTTS Asma Khalil (UK)

11:00-11:30 Coffee break

11:30-11:45 Laser for TTTS: Results of the Solomon trial Dick Oepkes (Netherlands)11:45-11:55 Laser for TTTS: Trends in referral and outcome in 10-year period Julien Stirnemann (France)11:55-12:05 Laser for TTTS: Fetal hemodynamics before and after surgery Francois Audibert (Canada)12.05-12:15 Laser for TTTS: Triplets Anne-Maude Morency (Canada)12:15-12:25 sFGR type 2: Expectant management / indications for cord occlusion Eduard Gratacos (Spain)12:25-12:35 sFGR type 2: Endoscopic laser Kypros Nicolaides (UK)

12:40-13:00 Best practice advice for Fetal Medicine by FIGO Gian Carlo Di Renzo (Italy)

13:00-14:00 Lunch break

14:30-15:40 Fetal and postnatal surgery Discussants: Jan Deprest (Belgium), Alexandra Benachi (France), Alan Flake (USA)

14:30-14:45 Diaphragmatic hernia: Genetics Daryl Armstrong Scott (USA)14:45-14:55 Diaphragmatic hernia: Update on the FETO trial Jan Deprest (Belgium)14:55-15:05 Diaphragmatic hernia: Right-sided disease Jute Richter (Belgium)15:05-15:15 Diaphragmatic hernia: VEGF promotes lung growth Julio Jimenez (Chile)15:15-15:25 Esophageal atresia: Genetics Daryl Armstrong Scott (USA)15:25-15:35 Esophageal atresia: Prenatal diagnosis Emmanuel Spaggiari (France)

18:00-18:20 Prenatal use of array CGH Valérie Malan (France)

18:20-18:40 In utero stem cell transplantation Alan Flake (USA)

18:40-19:00 Cell free mRNA in pregnancy diseases Carl Weiner (USA)

19:00-20:00 Fetal imaging

19:00-19:30 MRI of the fetal brain Daniela Prayer (Austria)19:30-20:00 Early fetal development by 3D ultrasound Bernard Benoit (Monaco)

20:30-24:00 Welcome party

Sunday 29th June 2014

prenatal screen

carrier screen

miscarriage test (POC)

For more informat ionplease contact Natera:1-855-866-6478 [email protected]

www.panoramatest .com

The tests were developed by Natera, Inc., a laboratory certif ied under the Clinical Laboratory Improvement Amendments (CLIA). These tests have not been cleared or approved by the U.S. Food and Drug Administration (FDA).

prenatal screen

carrier screen


prenatal screen

carrier screen


prenatal screen

carrier screen


prenatal screen

carrier screen


PANORAMA:

PART OF THE NATERA

FAMILY OF PRODUCTS

The PanoramaTM Non-Invasive Prenatal Test (NIPT) has demonstrated >99% combined accuracy for T21, T18, T13, X and Y and Triploidy in published clinical trials.

• ARE COMMON AND CAN BE SEVERE

• CARRY EQUAL RISK ACROSS ALL MATERNAL AGES

• OFTEN GO UNDIAGNOSED

• RESPOND TO EARLY CHILDHOOD INTERVENTIONS

Now, Panorama can also screen for microdeletions that:

Please stop by our booth at World FMF to receive a copy of our just released white paper about the new Panorama microdeletion screening panel.

PLATINUM SPONSOR

Eurofoetus Meeting09:00-11:00 Fetal and postnatal surgery Discussants: Jan Deprest (Belgium), Kurt Hecher (Germany), Alan Flake (USA)

09:00-09:10 Spinabifida:Genetics DarylArmstrongScott(USA)09:10-09:25 Spinabifida:Minimallyinvasivetherapy DenisePedreira(Brazil)09:25-09:40 Spinabifida:Updateonopenfetalsurgery AlanFlake(USA)09:40-09:50 Sacro-coccygeal teratoma: Prenatal diagnosis Greg Ryan (Canada)09:50-10:00 Sacro-coccygeal teratoma: Long term outcome Francois Luks (USA)10:00-10:15 Lung lesions: Prenatal diagnosis Annegret Geipel (Germany)10:15-10:30 Lung lesions: Long term outcome Francois Luks (USA)10:30-10:40 Non-visiblegallbladder:Amnioticfluidenzymes EranAshwal(Israel)10:40-10:50 Non-visible gallbladder: Fetal biology Francoise Muller (France)10:50-11:00 Fetoscopic laser perforation of ureterocele Anne-Maude Morency (Canada)


11:30-11:45 Urinary tract defects: Prenatal diagnosis Christoph Berg (Germany)11:45-12:00 Urinary tract obstruction: Long term outcome Francois Luks (USA)12:00-12:10 Fetal renal function and long term outcome Francoise Muller (France)

12:10-13:00 Preterm birth Discussants: Roberto Romero (USA), Steve Thornton (UK)

12:10-12:40 PTB and PPROM: Mechanisms and consequences Roberto Romero (USA)12:40-13:00 PTB: Interventions for prevention Steve Thornton (UK)


14:30-16:00 Preterm birth Discussants: Roberto Romero (USA), Steve Thornton (UK)

14:30-14:45 PTB and PPROM: Biomechanics for prediction Edoardo Mazza (Switzerland)14:45-14:55 PTB: Prediction by cervical length in singletons Ioannis Papastefanou (Greece)14:55-15:05 PTB: Prediction by cervical length in twins Lindsay Kindinger (UK)15:05-15:15 PTB: Prediction by cervical length and T-regulatory lymphocytes Pavel Calda (Czechia)15:15-15:25 PTB: Prediction by cervical length in threatened PTB Liran Hiersch (Israel)15:25-15:35 PTB: RCT of cervical pessary in twins Elena Carreras (Spain)15:35-15:45 PTB: RCT of cervical pessary in twins Kypros Nicolaides (UK)

18:00-20:10 Fetal conditions / interventions and preterm birth Discussants: Jan Deprest (Belgium), Kurt Hecher (Germany), Yves Ville (France)

18:00-18:15 Monoamniotic twins Tim Van Mieghem (Belgium)18:15-18:30 Embryo reduction Luc De Catte (Belgium) 18:30-18:45 Thoracic and bladder shunts Greg Ryan (Canada)18:45-19:00 FETO and balloon removal Jan Deprest (Belgium)19:00-19:15 Open fetal surgery Alan Flake (USA)19:15-19:30 Tocolysis for fetal interventions Greg Ryan (Canada)19:30-19:40 Role of collagen plug Francois Luks (USA)19:40-19:50 Quantitative ultrasound assessment of fetal lung maturity Eduard Gratacos (Spain)19:50-20:05 Prediction of pulmonary hypoplasia by MRI in PPROM Daniela Prayer (Austria)

Monday 30th June 2014

PerkinElmer gives life a fi ghting chance with innovative prenatal screening solutions� First PlGF assay for both T21 and pre-eclampsia screening

� First bio-chemistry-only screening protocol for Down syndrome in the � rst trimester� Cost-e� ective contingent NIPT screening with PlGF and AFP markers

Products are not available in all countries. Please check the availability with your local PerkinElmer representative.

© 2

014

Perk

inEl

mer

, Inc

.. Al

l tra

dem

arks

or r

egist

ered

trad

emar

ks a

re th

e pr

oper

ty o

f Per

kinE

lmer

, Inc

. and

/or i

ts s

ubsid

iarie

s.

EARLIER CARE

BETTER CARE

www.perkinelmer.com/maternalfetalhealth


29 June to 3 July 2014 Nice, FrancePerkinElmer Booth No.1

FMF'14_ad_A5.indd 1 23.5.2014 10.11

GOLD SPONSOR

DIAMOND SPONSOR

13th World Congress in Fetal MedicineNice, France

Non-invasive examination of Trisomy using directed Cell-free DNA analysis in a large general pregnancy population: The NEXT StudyTrisomies 21, 18, 13 in singletons: The NEXT Study

Presenter: Thomas Musci, MD, Chief Medical Ocer, Ariosa DiagnosticsSession: Screening for aneuploidies by cfDNA analysis of maternal blood (17:00-20:10)Date: Tuesday, July 1st, 2014Time: 17:20 - 17:30

Visit us at Booth #18

09:00-11:00 Maternal Medicine Discussants: Catherine Williamson (UK), Catherine Nelson-Piercy (UK), Gerry Visser (Netherlands)

09:00-09:20 Thromboembolism Catherine Nelson-Piercy (UK)09:20-09:40 Cardiac disease Sara Thorne (UK)09:40-10:00 Renal disease Liz Lightstone (UK)10:00-10:20 Dermatology Samantha Vaughan-Jones (UK)10:20-10:40 Respiratory disease Ray Powrie (USA)10:40-11:00 Gastrointestinal disease Lucy MacKillop (UK)


11:30-11:50 Cholestasis Catherine Williamson (UK)11:50-12:30 Preexisting and gestational diabetes Moshe Hod (Israel) Gerry Visser (Netherlands)12:30-12:40 Placental expression of IGFs in diabetes and obesity Aamod Nawathe (UK)12:40-12:50 1st trimester prediction of maternal glycemic status Rinat Gabbay-Benziv (USA)12:50-13:00 1st trimester screening for GDM Argyro Syngelaki (UK)


14:30-15:30 GE Healthcare lectures:

14:30-15:00 3D US in the diagnosis of fetal defects Bernard Benoit (Monaco)15:00-15:30 2Dhighdefinitionlinearprobeinthe1st and 2nd trimesters Rabih Chaoui (Germany)

15:30-15:50 Postmortem imaging Neil Sebire (UK)

17:00-20:10 Screening for aneuploidies by cfDNA analysis of maternal blood Discussants: John Hyett (Australia) Jacques Jani (Belgium), Tak Yeung Leung (China), Ann Tabor (Denmark), Yves Ville, Alexandra Benachi (France), Rabih Chaoui (Germany), Howard Cuckle (Israel), Katia Bilardo, Dick Oepkes (Netherlands), Kypros Nicolaides (UK), Mark Evans (USA)

17:00-17:10 Overview Kypros Nicolaides (UK)

17:10-17:20 Trisomies 21, 18, 13: The CARE study Amy Sehnert (USA)17:20-17:30 Trisomies 21, 18, 13: The NEXT study Thomas Musci (USA)17:30-17:40 Trisomies 21, 18, 13: The UK study Mar Gil (UK)17:40-17:50 Incorporating cfDNA in the risk algorithm for aneuploidies David Wright (UK)17:50-18:05 Models for clinical implementation Howard Cuckle (Israel)18:05-18:35 Contingent vs universal screening Discussion

18:35-18:45 Twins: Zygocity assessment and aneuploidy detection Tak Yeung Leung (China)18:45-18:55 Twins: Screening for trisomies 21, 18, 13 Elisa Bevilaqua (Belgium)18:55-19:05 Twins: Total vs lowest fetal fraction Discussion

19:05-19:20 Value of screening for DiGeorge syndrome Sue Gross (USA)19:20-19:30 Screening for microdeletions / microduplications Mathias Ehrich (USA)19:30-19:40 Miscarriage from amniocentesis and CVS Ranjit Akolekar (UK)19:40-19:55 CVS with microarrays for everyone Mark Evans (USA)19:55-20:10 Diagnosis of microdeletions: cfDNA testing vs. invasive testing Discussion

21:00-01:30 Dinner party in Antibes

Tuesday 1st July 2014

For further information, please send your enquiries

to [email protected]

Medical minds think alike

Giving lightto every blossom

Booth number: 6#

Visit Mindray at FMF2014, be part of the

innovation and explore ultrasound

solutions created with your daily

challenges for more accurate diagnosis.

See more by scanningQR code

C

M

Y

CM

MY

CY

CMY

K

广告.pdf 1 2014-5-30 17:01:57 SILVER SPONSOR

SILVER SPONSORSILVER SPONSOR (white text in blue frame)

SILVER SPONSOR (white text in blue frame)

09:00-13:00 Impaired placentation Discussants: Eduard Gratacos (Spain), Ahmet Baschat (USA), Katia Bilardo (Netherlands)

09:00-09:20 Angiogenic factors in the diagnosis and management of PE Andrew Shennan (UK) 09:20-09:30 GH: Response to labetolol in prediction of outcome Nikos Kametas (UK)09:30-09:40 PE prediction: Combined screening at 11-13 weeks Meriem Guizani (Brussels)09:40-09:50 PE prediction: Combined screening at 11-13 weeks Julien Stirnemann (France)09:50-10:00 PE prediction: Combined screening, including LHCGR forms Francesca Crovetto (Spain)10:00-10:10 PE: Impact of aspirin after 1st trimester screening Jon Hyett (Australia)10:10-10:20 PE prevention: Going beyond aspirin Ahmet Baschat (USA)10:20-10:27 PE prevention: The ASPRE study Leona Poon (UK)10:27-10:35 PE-FGR at term: Relation to uterine artery PI at 19-22 weeks Jose Moratalla (Spain)10:35-10:43 PE prediction: Combined screening at 20-24 weeks Dahiana Gallo (UK)10:43-10:50 PE prediction: Combined screening at 30-34 weeks Jonathan Lai (UK)10:50-11:00 PE and FGR: a new prediction algorithm David Wright (UK)


11:30-11:40 FGRlate:Redefinedbycerebral-to-placentalratio AsmaKhalil(UK)11:40-11:50 Optimal fetal growth Gerry Visser (Netherlands)11:50-12:00 FGR early: Prenatal prediction of acidemia Ahmet Baschat (USA)12:00-12:10 FGR late: Fetal brain metabolism Magda Sanz-Cortes (Spain)12:10-12:20 FGR:Metabolicandcardiovascularprofileat3-4years ElisaLlurba(Spain)12:20-12:30 FGR: Fetal brain MRI: predictor of neurodevelopment at 2 years Gabriela Egaña-Ugrinovic (Spain)12:30-12:40 FGR: Effect of postnatal diet on reverting cardiovascular remodeling Fatima Crispi (Spain)12:40-13:00 FGR: integrated diagnosis and management algorithm Eduard Gratacos (Spain)


14:30-16:15 Brain abnormalities Discussants: Rabih Chaoui (Germany), Magda Sanz-Cortes (Spain)

14:30-15:00 Evolution in brain abnormalities Rabih Chaoui (Germany)15:00-15:20 Posterior fossa abnormalities Magda Sanz-Cortes (Spain)15:20-15:35 Encephalocele:1sttrimestersonographicspectrumoffindings WaldoSepulveda(Chile)15:35-15:45 Openspinabifida:1st trimester BPD to TAD ratio Emmanuel Simon (France)15:45-15:55 Openspinabifida:1st trimester diagnosis – meta analysis Cristina Rossi (Italy)15:55-16:05 Openspinabifida:1st trimester impaired cortical development Robert Lachmann (Germany)

18:00-19:40 Brain abnormalities Discussants: Rabih Chaoui (Germany), Magda Sanz-Cortes (Spain)18:00-18:10 Anencephaly: Timing of detection in the Netherlands Hanneke Fleurke (Netherlands)18:10-18:20 Feasibility of visualizing the cerebellum at 11-13 weeks Reem Abu-Rustum (Lebanon)18:20-18:30 Sonographic evaluation of pericallosal circulation at 11-22 weeks Bart De Keersmaecker (Belgium)18:30-18:40 Thrombosis of the torcular herophili Waldo Sepulveda (Chile)18:40-18:50 Periventricular pseudocysts and neurodevelopmental outcome Denise Pugash (Canada)18:50-19:00 Ultrasound detection of olfactory sulci in normal fetuses Marta Acanforta (France)19:00-19:10 FetalBrainMRI:Novelclassificationandcontributiontosonography EldadKatorza(Israel)19:10-19:20 Evaluation of fetal vermis: 2D-US, 3D-US, MRI Eldad Katorza (Israel)

19:40-20:00 Genes and activity in brain development Yehezkel Ben-Ari (France)

Wednesday 2nd July 2014

BRONZE SPONSOR

• Incubation time of only 9 minutes

• Exceptional precision and sensitivity

• Fast and reliable detection of clinical

values throughout pregnancy

thermoscientific.com/brahms

NEWin the

Thermo Scie

ntific

Biomarker

s

panel

Complete pre-eclampsia portfolioFrom safe screening to improved diagnosis

B·R·A·H·M·S sFlt-1 KRYPTOR

PlGF-Ad_RZ_Layout 1 03.06.14 12:50 Seite 1

STANDARD SPONSORS

08:30-11:00 Fetal echocardiography Discussants: Rabih Chaoui (Germany), Katia Bilardo (Netherlands), Fanny Bajolle (France)

08:30-08:40 1st trimester screening for heart defects Weijing Li (China)08:40-08:50 Post-mortem micro-CT of early heart defects Claudio Lombardi (Italy)08:50-09:10 Genetics of cardiac malformations Fanny Bajolle (France)09:10-10:10 Systematic approach for diagnosis of heart defects Rabih Chaoui (Germany)10:10-10:30 Umbilico-portosystemic shunts - A cryptic disease Reuven Achiron (Israel)10:30-10:40 Head growth in newborns with heart defects Julien Stirnemann (France)10:40-10:50 Abnormal brain development in fetuses with heart defects Magda Sanz-Cortes (Spain)


11:30-12:00 Cytomegalovirus infection Discussants: Jacques Jani (Belgium), Yves Ville (France)

11:30-11:45 Neonatal CMV: Prediction in fetuses without brain anomalies Yves Ville (France)11:45-12:00 Neonatal CMV: Prediction by fetal MRI Jacques Jani (Belgium)

12:00-12:15 Prenatal diagnosis of Noonan syndrome Katia Bilardo (Netherlands)

12:15-13:00 Labor and delivery Discussants: Jacques Jani (Belgium), Yves Ville (France)

12:15-12:25 Timing of external breech to cephalic version Jose Ferreira (Poland)12:25-12:35 Prenatal prediction of placenta accreta Jeni Panaiotova (UK)12:35-12:45 RCT: CS scar thickness 2 years after single- or double-layer closure Christian Bamberg (Germany)12:45-13:00 Pregnancy, labor and delivery of HRH Princess Charlotte Francis Carmody (Australia)


15:00-23:00 Trip to Cannes

Thursday 3rd July 2014

STANDARD SPONSORS

Advances in Fetal Medicine Course6-7 December 2014

London

Registration will open in August 2014Limited Number of places

Fetal and neonatal medicine from basic research to clinical practice

Reviews

205 How to Monitor the Brain during Immediate Neonatal Transition and Resuscitation? A Systematic Qualitative Review of the LiteraturePichler, G. (Edmonton, Alta./Graz); Cheung, P.-Y.; Aziz, K. (Edmonton, Alta.); Urlesberger, B. (Graz); Schmölzer, G.M. (Edmonton, Alta./Graz)

230 Measuring Physiological Changes during the Transition to Life after Birth van Vonderen, J.J.; Roest, A.A.W. (Leiden); Siew, M.L. (Melbourne, Vic.); Walther, F.J. (Leiden); Hooper, S.B. (Melbourne, Vic.); te Pas, A.B. (Leiden)

Systematic Review and Meta-Analysis

189 Chorioamnionitis as a Risk Factor for Retinopathy of Prematurity: A Systematic Review and Meta-AnalysisMitra, S. (Oslo/Hamilton, Ont.); Aune, D. (Trondheim/London); Speer, C.P. (Würzburg); Saugstad, O.D. (Oslo)

Original Papers

161 Early End-Tidal Carbon Monoxide Levels, Patency of the Ductus Arteriosus and Regional Cerebral Oxygenation in Preterm InfantsDix, L.M.L.; Blok, C.A.; Lemmers, P.M.A.; van der Aa, N.; Molenschot, M.C. (Utrecht); Vreman, H.J. (Stanford, Calif.); Krediet, T.; van Bel, F. (Utrecht)

166 High Prevalence of Severe Circulatory Complications with Diazoxide in Premature InfantsYoshida, K.; Kawai, M.; Marumo, C.; Kanazawa, H.; Matsukura, T. (Kyoto); Kusuda, S. (Tokyo); Yorifuji, T. (Osaka); Heike, T. (Kyoto)

175 Differences in the Maturation of Amplitude-Integrated EEG Signals in Male and Female Preterm InfantsGriesmaier, E.; Santuari, E.; Edlinger, M.; Neubauer, V.; Waltner-Romen, M.; Kiechl-Kohlendorfer, U. (Innsbruck)

211 Purified Human Breast Milk MUC1 and MUC4 Inhibit Human Immunodeficiency VirusMthembu, Y.; Lotz, Z.; Tyler, M. (Cape Town); de Beer, C. (Parow); Rodrigues, J.; Schoeman, L.; Mall, A.S. (Cape Town)

218 Eight Years Later, Are We Still Hurting Newborn Infants?Roofthooft, D.W.E. (Rotterdam); Simons, S.H.P. (Amsterdam); Anand, K.J.S. (Memphis, Tenn.); Tibboel, D.; van Dijk, M. (Rotterdam)

Fetal and Neonatal Research

(Continued on inside front cover)

van Vonderen, J.J.; Roest, A.A.W. (Leiden); Siew, M.L. (Melbourne, Vic.); Walther, F.J. (Leiden); Hooper, S.B.

Chorioamnionitis as a Risk Factor for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis

(Trondheim/London); Speer, C.P. (Würzburg); Saugstad, O.D.

Yoshida, K.; Kawai, M.; Marumo, C.; Kanazawa, H.; Matsukura, T. (Kyoto); Kusuda, S. (Tokyo); Yorifuji, T. (Osaka); Heike, T. (Kyoto)

175 Differences in the Maturation of Amplitude-Integrated EEG Signals in Male and Female Preterm InfantsGriesmaier, E.; Santuari, E.; Edlinger, M.; Neubauer, V.;

Eight Years Later, Are We Still Hurting Newborn

Roofthooft, D.W.E. (Rotterdam); Simons, S.H.P. (Amsterdam); Anand, K.J.S. (Memphis, Tenn.); Tibboel, D.; van Dijk, M. (Rotterdam)

(Continued on inside front cover)

Prematurity: A Systematic Review and Meta-Analysis

Integrated EEG Signals in Male and Female Preterm

Griesmaier, E.; Santuari, E.; Edlinger, M.; Neubauer, V.; Waltner-Romen, M.; Kiechl-Kohlendorfer, U. (Innsbruck)

Mthembu, Y.; Lotz, Z.; Tyler, M. (Cape Town); de Beer, C. (Parow); Rodrigues, J.; Schoeman, L.; Mall, A.S. (Cape Town)

Eight Years Later, Are We Still Hurting Newborn Infants?Roofthooft, D.W.E. (Rotterdam); Simons, S.H.P. (Amsterdam);

(Trondheim/London); Speer, C.P. (Würzburg); Saugstad, O.D.

Integrated EEG Signals in Male and Female Preterm

Griesmaier, E.; Santuari, E.; Edlinger, M.; Neubauer, V.; Waltner-Romen, M.; Kiechl-Kohlendorfer, U. (Innsbruck)

211 Purified Human Breast Milk MUC1 and MUC4 Inhibit

218Impact facto

r: 2.573Impact facto








r: 2.573Mthembu, Y.; Lotz, Z.; Tyler, M. (Cape Town); de Beer, C. Impact facto



r: 2.573Mthembu, Y.; Lotz, Z.; Tyler, M. (Cape Town); de Beer, C. (Parow); Rodrigues, J.; Schoeman, L.; Mall, A.S. (Cape Town)Impact facto

r: 2.573(Parow); Rodrigues, J.; Schoeman, L.; Mall, A.S. (Cape Town)Impact facto


r: 2.573(Parow); Rodrigues, J.; Schoeman, L.; Mall, A.S. (Cape Town)

Eight Years Later, Are We Still Hurting Newborn Impact facto

r: 2.573 Eight Years Later, Are We Still Hurting Newborn

Impact factor: 2.573

















Impact factor: 2.573Griesmaier, E.; Santuari, E.; Edlinger, M.; Neubauer, V.;



Impact factor: 2.573Griesmaier, E.; Santuari, E.; Edlinger, M.; Neubauer, V.; Waltner-Romen, M.; Kiechl-Kohlendorfer, U. (Innsbruck)

Impact factor: 2.573Waltner-Romen, M.; Kiechl-Kohlendorfer, U. (Innsbruck)

Impact factor: 2.573Waltner-Romen, M.; Kiechl-Kohlendorfer, U. (Innsbruck)

Impact factor: 2.573Waltner-Romen, M.; Kiechl-Kohlendorfer, U. (Innsbruck)211



Impact factor: 2.573211 Purified Human Breast Milk MUC1 and MUC4 Inhibit




Human Immunodeficiency VirusImpact factor: 2.573



Human Immunodeficiency VirusMthembu, Y.; Lotz, Z.; Tyler, M. (Cape Town); de Beer, C. Impact facto



r: 2.573Mthembu, Y.; Lotz, Z.; Tyler, M. (Cape Town); de Beer, C. (Parow); Rodrigues, J.; Schoeman, L.; Mall, A.S. (Cape Town)Impact facto



r: 2.573(Parow); Rodrigues, J.; Schoeman, L.; Mall, A.S. (Cape Town)

218Impact facto



r: 2.573218 Eight Years Later, Are We Still Hurting Newborn Impact facto











Editor-in-Chief

E. Gratacós, Barcelona

Fetal Diagnosis and Therapy2014: Volumes 34, 354 issues per volumeLanguage: EnglishISSN 1015–3837 (print)ISSN 1421–9964 (online)

Editors-in-Chief

H.L. Halliday, BelfastC.P. Speer, Würzburg

Neonatology2014: Volumes 105, 1064 issues per volumeLanguage: EnglishISSN 1661–7800 (print)ISSN 1661–7819 (online)

www.karger.com/fdt www.karger.com/neo

Listed in bibliographic services, includingCurrent Contents®, MEDLINE, Biological Abstracts, EMBASE/Excerpta Medica

More information on the journal websites:• Pay-per-View and

Subscriber Access to Full Text• Full Table of Contents• Full Editorial Board• Free Abstracts and Selected Articles• Online Sample Issue• Submission/Guidelines for Authors• Subscription Details• Free Alert Service• Online Library Recommendation

New Advances in Cell-Free DNA Analysis of Maternal BloodGuest EditorKypros Nicolaides, London

S. KargerMedical and Scientifi c PublishersBasel . Freiburg . Paris . London . New York . Bangalore . Bangkok . Shanghai . Singapore . Tokyo . Sydney

Fetal Diagn Ther35(3) 151–228 (2014) 35 | 3 | 14

printISSN 1015–3837

onlinee-ISSN 1421–9964

www.karger.com/fdt

ISBN 978–3–318–02692–4

Don‘t miss the free special is

sue

‚New Advances in Cell-Free

DNA Analysis of Maternal B

lood‘

in your delegate bag!











































KI1

4700

Reem Abu-Rustum (Lebanon)Marta Acanforta (France)Reuven Achiron (Israel)Ranjit Akolekar (UK)Daryl Armstrong Scott (USA)Eran Ashwal (Israel)Francois Audibert (Canada)Fanny Bajolle (France)Christian Bamberg (Germany)Ahmet Baschat (USA)Yehezkel Ben-Ari (France)Alexandra Benachi (France)Bernard Benoit (Monaco)Christoph Berg (Germany)Elisa Bevilaqua (Belgium)Katia Bilardo (Netherlands)Isaac Blickstein (Israel)Pavel Calda (Czechia)Elena Carreras (Spain)Francis Carmody (Australia)Petya Chaveeva (Bulgaria)Rabih Chaoui (Germany)Fatima Crispi (Spain)Francesca Crovetto (Spain)Howard Cuckle (Israel)Luc De Catte (Belgium)Bart De Keersmaecker (Belgium)Jan Deprest (Belgium)Gian Carlo Di Renzo (Italy)Gabriela Egaña-Ugrinovic (Spain)Mathias Ehrich (USA)Mark Evans (USA)Jose Ferreira (Poland)Alan Flake (USA)Hanneke Fleurke (Netherlands)

Rinat Gabbay-Benziv (USA)Dahiana Gallo (UK)Annegret Geipel (Germany)Mar Gil (UK)Eduard Gratacos (Spain)Sue Gross (USA)Meriem Guizani (Brussels)Kurt Hecher (Germany)Liran Hiersch (Israel)Moshe Hod (Israel)Jon Hyett (Australia)Jacques Jani (Belgium)Julio Jimenez (Chile)Nikos Kametas (UK)Eldad Katorza (Israel)Asma Khalil (UK)Lindsay Kindinger (UK)Robert Lachmann (Germany)Jonathan Lai (UK)Tak Yeung Leung (China)Liesbeth Lewi (Belgium)Weijing Li (China)Liz Lightstone (UK)Elisa Llurba (Spain)Claudio Lombardi (Italy)Francois Luks (USA)Lucy MacKillop (UK)Valérie Malan (France)Edoardo Mazza (Switzerland)Jose Moratalla (Spain)Anne-Maude Morency (Canada)Francoise Muller (France)Thomas Musci (USA)Aamod Nawathe (UK)Catherine Nelson-Piercy (UK)

Kypros Nicolaides (UK)Dick Oepkes (Netherlands)Jeni Panaiotova (UK)Ioannis Papastefanou (Greece)Denise Pedreira (Brazil)Leona Poon (UK)Ray Powrie (USA)Daniela Prayer (Austria)Denise Pugash (Canada)Jute Richter (Belgium)Roberto Romero (USA)Cristina Rossi (Italy)Greg Ryan (Canada)Magda Sanz-Cortes (Spain)Neil Sebire (UK)Amy Sehnert (USA)Waldo Sepulveda (Chile)Andrew Shennan (UK)Emmanuel Simon (France)Emmanuel Spaggiari (France)Julien Stirnemann (France)Argyro Syngelaki (UK)Ann Tabor (Denmark)Sara Thorne (UK)Steve Thornton (UK)Tim Van Mieghem (Belgium)Samantha Vaughan-Jones (UK)Cathrine Vedel (Denmark)Yves Ville (France)Gerry Visser (Netherlands)Carl Weiner (USA)Boaz Weisz (Israel)Catherine Williamson (UK)David Wright (UK)

Speakers:

The Fetal Medicine FoundationUK Charity Number 1037116137 Harley Street, London, W1G 6BG, UKTel: +44 (0) 207 034 3070www.fetalmedicine.com

13th world congress in fetal medicine...2014/01/02 · 13th world congress in fetal medicine sunday...

Documents